Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis

Author:

Meng Hu1ORCID,Sengupta Arjun2ORCID,Ricciotti Emanuela12,Mrčela Antonijo1,Mathew Divij23,Mazaleuskaya Liudmila L.1,Ghosh Soumita1,Brooks Thomas G.1,Turner Alexandra P.4,Schanoski Alessa Soares5,Lahens Nicholas F.1,Tan Ai Wen2,Woolfork Ashley2,Grant Greg16,Susztak Katalin4,Letizia Andrew G.78,Sealfon Stuart C.5,Wherry E. John23,Laudanski Krzysztof9,Weljie Aalim M.12,Meyer Nuala J.14,FitzGerald Garret A.124ORCID

Affiliation:

1. Institute for Translational Medicine and Therapeutics Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

2. Department of Systems Pharmacology and Translational Therapeutics Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

3. Institute for Immunology and Immune Health Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

4. Department of Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

5. Department of Neurology Icahn School of Medicine at Mount Sinai New York New York USA

6. Department of Genetics Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

7. Naval Medical Research Center Silver Spring Maryland USA

8. Naval Medical Research Unit TWO Singapore Singapore

9. Department of Anesthesiology and Critical Care Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

Abstract

AbstractBackgroundLipids may influence cellular penetrance by viral pathogens and the immune response that they evoke. We deeply phenotyped the lipidomic response to SARs‐CoV‐2 and compared that with infection with other pathogens in patients admitted with acute respiratory distress syndrome to an intensive care unit (ICU).MethodsMass spectrometry was used to characterise lipids and relate them to proteins, peripheral cell immunotypes and disease severity.ResultsCirculating phospholipases (sPLA2, cPLA2 (PLA2G4A) and PLA2G2D) were elevated on admission in all ICU groups. Cyclooxygenase, lipoxygenase and epoxygenase products of arachidonic acid (AA) were elevated in all ICU groups compared with controls. sPLA2 predicted severity in COVID‐19 and correlated with TxA2, LTE4 and the isoprostane, iPF2α‐III, while PLA2G2D correlated with LTE4. The elevation in PGD2, like PGI2 and 12‐HETE, exhibited relative specificity for COVID‐19 and correlated with sPLA2 and the interleukin‐13 receptor to drive lymphopenia, a marker of disease severity. Pro‐inflammatory eicosanoids remained correlated with severity in COVID‐19 28 days after admission. Amongst non‐COVID ICU patients, elevations in 5‐ and 15‐HETE and 9‐ and 13‐HODE reflected viral rather than bacterial disease. Linoleic acid (LA) binds directly to SARS‐CoV‐2 and both LA and its di‐HOME products reflected disease severity in COVID‐19. In healthy marines, these lipids rose with seroconversion. Eicosanoids linked variably to the peripheral cellular immune response. PGE2, TxA2 and LTE4 correlated with T cell activation, as did PGD2 with non‐B non‐T cell activation. In COVID‐19, LPS stimulated peripheral blood mononuclear cell PGF2α correlated with memory T cells, dendritic and NK cells while LA and DiHOMEs correlated with exhausted T cells. Three high abundance lipids – ChoE 18:3, LPC‐O‐16:0 and PC‐O‐30:0 – were altered specifically in COVID. LPC‐O‐16:0 was strongly correlated with T helper follicular cell activation and all three negatively correlated with multi‐omic inflammatory pathways and disease severity.ConclusionsA broad based lipidomic storm is a predictor of poor prognosis in ARDS. Alterations in sPLA2, PGD2 and 12‐HETE and the high abundance lipids, ChoE 18:3, LPC‐O‐16:0 and PC‐O‐30:0 exhibit relative specificity for COVID‐19 amongst such patients and correlate with the inflammatory response to link to disease severity.

Funder

National Institutes of Health

Defense Advanced Research Projects Agency

Defense Health Agency

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3